Diabetes 43:535539 Parkes D, Jodka C, Smoth P et al (2001) Pharmacokinetic actions of exendin-4 in the rat: comparison with glucagon-like peptide-1
10 mg vial + 2 mL BAC water: Concentration = 5,000 mcg/mL (5 mg/mL) 5 mg dose = 100 units (1.0 mL) on a 100-unit insulin syringe 10 mg dose = entire vial (use two 100-unit draws or reconstitute with 1 mL for 10 mg/mL) Doses per vial: 2 doses at 5 mg, or 1 dose at 10 mg Supplies Needed (20-Day Cycle at 5 mg/day) 10 vials Epithalon (10 mg each) provides 20 doses at 5 mg 1 vial bacteriostatic water (30 mL) 20 insulin syringes (2931 gauge, 100-unit) Alcohol prep pads Administration Injection Technique Epithalon is administered via subcutaneous (SubQ) injection
Additionally, CT scans revealed declines in vBMD across all groups, with the smallest reduction in the resistance group, suggesting a potential protective effect against bone loss
The Mechanism of Action: How They Work in Your Body The power of peptides lies in their ability to bind to specific receptors on cell surfaces, essentially acting like a key that fits a very precise lock, triggering a beneficial biological response
After matching the two groups by key baseline characteristics, the team compared 10,339 tirzepatide-treated patients with 10,339 semaglutide-treated patients
The decision to discontinue GLP-1 analogue treatments should be made in consultation with your healthcare provider
